알레르기 진단 시장 규모, 점유율, 성장 분석 : 제품 및 서비스별, 검사별, 알레르겐별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Allergy Diagnostics Market size was valued at USD 4.80 Billion in 2024 and is poised to grow from USD 5.33 Billion in 2025 to USD 12.28 Billion by 2033, growing at a CAGR of 11% during the forecast period (2026-2033).

The global allergy diagnostics market is experiencing significant growth driven by the increasing prevalence of allergic conditions, advancements in diagnostic technologies, and heightened public awareness surrounding allergy testing. Common allergic disorders, including hay fever, asthma, and food allergies, are on the rise, attributable to various environmental and lifestyle factors. Innovations such as skin prick tests, in vitro testing, and molecular diagnostics are enhancing accuracy and efficiency within the sector. However, challenges such as regulatory hurdles, high costs of advanced diagnostics, and a lack of standardization may hinder market expansion. Despite these obstacles, emerging innovative diagnostic methods, the integration of machine learning and artificial intelligence, along with increased investment in healthcare infrastructure, present considerable opportunities for future growth within the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Diagnostics Market

The growing trend towards personalized medicine is significantly influencing the allergy diagnostics market. There is a rising demand for allergy testing that provides comprehensive insights into individual sensitivities, facilitating more tailored treatment options. Advances in research focused on identifying specific biomarkers linked to allergies enhance the capacity to develop customized treatment strategies, further propelling the growth of the allergy diagnostics sector. As healthcare moves towards more individualized approaches, the emphasis on precision in diagnosing and treating allergies is becoming increasingly crucial, ultimately shaping the future landscape of allergy diagnostics.

Restraints in the Global Allergy Diagnostics Market

The growth of the global allergy diagnostics market is being hindered by the increasing popularity of home testing kits and do-it-yourself approaches. While these home-based allergy testing solutions provide greater convenience for patients, they often lack the accuracy of laboratory-based diagnostics. This shift in preference can lead to a decline in the demand for professional testing services, ultimately impacting market expansion. Additionally, the tendency for patients to explore DIY methods and home remedies further detracts from the traditional allergy diagnostics industry. Consequently, reliance on less precise home testing options poses a notable challenge to overall market development.

Market Trends of the Global Allergy Diagnostics Market

The Global Allergy Diagnostics market is witnessing a significant trend towards the increased adoption of molecular diagnostics, which includes advanced techniques such as allergen component testing and next-generation sequencing. These technologies enhance the accuracy of allergen detection at the molecular level, leading to highly personalized treatment plans based on individual patient sensitivities. As healthcare providers recognize the value of precision diagnostics, the ability to deliver tailored therapies is expected to improve patient outcomes considerably. Additionally, the prevalent use of methodologies like ELISA, PCR, and NHS further fuels the market's evolution, contributing to a more sophisticated and effective approach to allergy management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Assay Kits
• Instruments
• Services
• Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2026-2033)

• Market Overview
• In-vivo Tests
• In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2026-2033)

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Laboratories
• Hospital-Based Laboratories
• Academic Research Institutes
• Other End Users

Global Allergy Diagnostics Market Size & CAGR (2026-2033)

• North America (Product & Services, Tests, Allergen, End User)
  • US
  • Canada
• Europe (Product & Services, Tests, Allergen, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Tests, Allergen, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Tests, Allergen, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Tests, Allergen, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phadia (part of Thermo Fisher Scientific) (Sweden/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations